December 21, 2021 by Fightec.org
https://www.globenewswire.com/news-release/2021/12/20/2355050/0/en/Novartis-strengthens-immunotherapy-pipeline-with-option-collaboration-and-license-agreement-with-BeiGene-for-TIGIT-inhibitor-ociperlimab.html